In the present study, it was demonstrated that APS could down-regulate the suppressive activity of CD4+CD25+Tregs, which was associated with marked decrease in Foxp3 expression of peripheral blood Tregs both in vivo and ex vivo. The gene discussed is FOXP3; the disease is autoimmune polyendocrinopathy.